HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Topical lomefloxacin twice daily compared with fucidic acid in acute bacterial conjunctivitis.

Abstract
Forty-five patients with presumed acute bacterial conjunctivitis were treated in an investigator-masked randomized multicenter study with either lomefloxacin 0.3% or fucidic acid 1% eye drops twice daily. Clinical signs and symptoms were rated by slit-lamp examination and conjunctival swab cultures were performed to evaluate clinical and microbiological efficacy. A total of 57 ocular isolates were tested for susceptibility to nine antibiotics. A significant decrease in clinical symptomatology was achieved by both treatments with a gradual improvement over the treatment period of 7-9 days. Bacteriological recovery was frequently achieved already at the first control visit (day 3-5), but the recovery rate was statistically significant (p = 0.014) only in the lomefloxacin group. The relatively high in vitro resistance rate (46%) to fucidic acid was not reflected by lower clinical efficacy. Two unrelated adverse events (one in each treatment group) and minimal local intolerance problems were observed in both treatment groups. A significantly higher incidence of burning sensation was observed with fucidic acid than with lomefloxacin (p < 0.01). All four treatment failures in the study occurred in the fucidic acid group. Lomefloxacin 0.3% ophthalmic solution demonstrated a high efficacy and good tolerance in the management of acute bacterial conjunctivitis.
AuthorsK Malminiemi, O Kari, M L Latvala, R Voutilainen, A Miettinen, A Jauch
JournalActa ophthalmologica Scandinavica (Acta Ophthalmol Scand) Vol. 74 Issue 3 Pg. 280-4 (Jun 1996) ISSN: 1395-3907 [Print] Denmark
PMID8828727 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
Chemical References
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Fluoroquinolones
  • Ophthalmic Solutions
  • Quinolones
  • Fusidic Acid
  • lomefloxacin
Topics
  • Acute Disease
  • Administration, Topical
  • Anti-Bacterial Agents (administration & dosage, adverse effects, therapeutic use)
  • Anti-Infective Agents (administration & dosage, therapeutic use)
  • Bacteria (isolation & purification)
  • Colony Count, Microbial
  • Conjunctiva (microbiology)
  • Conjunctivitis, Bacterial (drug therapy, pathology)
  • Double-Blind Method
  • Drug Resistance
  • Fluoroquinolones
  • Fusidic Acid (administration & dosage, adverse effects, therapeutic use)
  • Humans
  • Microbial Sensitivity Tests
  • Ophthalmic Solutions
  • Quinolones (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: